1) Ascorbyl Palmitate
棕榈酸维生素C酯
1.
Enzymatic Synthesis of Ascorbyl Palmitate and Study of Its Spectral Specificity;
酶促合成棕榈酸维生素C酯及其光谱表征
2) isoascorbyl palmitate
异维生素C棕榈酸酯
1.
Kinetics of formation of isoascorbyl palmitate by lipase-catalyzed esterification;
脂肪酶催化合成异维生素C棕榈酸酯及其动力学
3) vitamin C palmitate
维生素C棕榈酸酯
1.
As an antioxidant,vitamin C palmitate was used as an additive in many countries.
维生素C棕榈酸酯是一种良好的抗氧化剂,在许多国家己批准作为抗氧化剂使用。
4) vitamin A plamitate
维生素A棕榈酸酯
1.
Novozym 435 was used for the synthesis of vitamin A plamitate.
对催化合成维生素A棕榈酸酯反应的脂肪酶和反应介质进行了比较,同时对影响合成维生素A棕榈酸酯反应的因素(温度、初始水含量、底物摩尔比、反应时间和酶量等)进行了探讨,优化了反应条件:在10mL不含水分的正己烷中,0。
2.
The synthesis of vitamin A plamitate in organic solvent with vitamin A acetate and ethyl palmitate with immobilized lipase from Candida sp.
研究了有机溶剂中脂肪酶催化维生素A棕榈酸酯的合成工艺。
5) retinol palmitate
维生素A棕榈酸酯
1.
A nonaqueousRP-HPLC method for determination of retinol palmitate, ergocalciferol, vitamin E acetate and phytonadione was established.
建立了非水反相高效液相色谱法同时测定4种脂溶性维生素——维生素A棕榈酸酯、维生素D2、维生素E醋酸酯、维生素K1的含量。
2.
Objective: To establish nonaqueous RP-HPLC to determine retinol palmitate、colecalciferol and vitamin E acetate in multi-vitamin injection simultaneously.
目的:用非水反相高效液相色谱法建立复合维生素注射液中维生素A棕榈酸酯、维生素D3和维生素E醋酸酯的含量测定方法。
3.
OBJECTIVE To establish an HPLC method for simultaneous determination of retinol palmitate,vitamin D2, vitamin E and vitamin K1 in fat-soluble vitamin for injection.
目的建立高效液相色谱法同时测定注射用脂溶性维生素中维生素A棕榈酸酯、维生素D2、E、K1含量的方法。
6) Vitamin A palmitate
维生素A棕榈酸酯
1.
RESULTS: The linear ranges of Vitamin D2, Vitamin E acetic ester and Vitamin A palmitate were 0.
结果:维生素D2、维生素E醋酸酯与维生素A棕榈酸酯检测浓度的线性范围分别为0。
2.
The aim was to prepare a novel ocular cationic microemulsion-in situ gel(CM-ISG) system with vitamin A palmitate (VAP) as model drug,and investigate the corneal retention behavior and corneal irritation of the system.
设计了新型眼用阳离子微乳-原位凝胶(cationic microemulsion-in situgel,CM-ISG)系统,以维生素A棕榈酸酯(vitamin A palmitate,VAP)为模型药物研究了该释药系统的角膜滞留特性,并评价了角膜刺激性。
补充资料：盐酸克林霉素棕榈酸酯
分子式：暂无
分子量：暂无
CAS号：25507-04-4
性质：暂无
制备方法：暂无
用途：林可霉素衍生物。
分子量：暂无
CAS号：25507-04-4
性质：暂无
制备方法：暂无
用途：林可霉素衍生物。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条